Literature DB >> 30792303

A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels.

Marcus Schewe1, Han Sun2, Ümit Mert3, Alexandra Mackenzie4,5,6, Ashley C W Pike4, Friederike Schulz3, Cristina Constantin7,8, Kirsty S Vowinkel9, Linus J Conrad5,6, Aytug K Kiper9, Wendy Gonzalez10,11, Marianne Musinszki3, Marie Tegtmeier3, David C Pryde12, Hassane Belabed13, Marc Nazare13, Bert L de Groot14, Niels Decher9, Bernd Fakler7,8, Elisabeth P Carpenter4,5, Stephen J Tucker5,6, Thomas Baukrowitz1.   

Abstract

Potassium (K+) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K+ channels gated at their selectivity filter (SF), including many two-pore domain K+ (K2P) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca2+)-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K+ occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K+ channel activators and highlight a filter gating machinery that is conserved across different families of K+ channels with implications for rational drug design.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30792303      PMCID: PMC6982535          DOI: 10.1126/science.aav0569

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  34 in total

Review 1.  Structural correlates of selectivity and inactivation in potassium channels.

Authors:  Jason G McCoy; Crina M Nimigean
Journal:  Biochim Biophys Acta       Date:  2011-09-16

2.  State-independent block of BK channels by an intracellular quaternary ammonium.

Authors:  Christina M Wilkens; Richard W Aldrich
Journal:  J Gen Physiol       Date:  2006-09       Impact factor: 4.086

3.  Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.

Authors:  Dawon Kang; Changyong Choe; Donghee Kim
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

Review 4.  Potassium channel blockers and openers as CNS neurologic therapeutic agents.

Authors:  Susan I V Judge; Paul J Smith; Peggy E Stewart; Christopher T Bever
Journal:  Recent Pat CNS Drug Discov       Date:  2007-11

5.  Asymmetric mechanosensitivity in a eukaryotic ion channel.

Authors:  Michael V Clausen; Viwan Jarerattanachat; Elisabeth P Carpenter; Mark S P Sansom; Stephen J Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

6.  Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.

Authors:  Jun Zhou; Corinne E Augelli-Szafran; Jenifer A Bradley; Xian Chen; Bryan J Koci; Walter A Volberg; Zhuoqian Sun; Jason S Cordes
Journal:  Mol Pharmacol       Date:  2005-06-23       Impact factor: 4.436

7.  K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.

Authors:  Yin Yao Dong; Ashley C W Pike; Alexandra Mackenzie; Conor McClenaghan; Prafulla Aryal; Liang Dong; Andrew Quigley; Mariana Grieben; Solenne Goubin; Shubhashish Mukhopadhyay; Gian Filippo Ruda; Michael V Clausen; Lishuang Cao; Paul E Brennan; Nicola A Burgess-Brown; Mark S P Sansom; Stephen J Tucker; Elisabeth P Carpenter
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

8.  2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.

Authors:  Earl Gordon; Irina M Lozinskaya; Zuojun Lin; Simon F Semus; Frank E Blaney; Robert N Willette; Xiaoping Xu
Journal:  Mol Pharmacol       Date:  2007-11-27       Impact factor: 4.436

9.  Multiple modalities converge on a common gate to control K2P channel function.

Authors:  Sviatoslav N Bagriantsev; Rémi Peyronnet; Kimberly A Clark; Eric Honoré; Daniel L Minor
Journal:  EMBO J       Date:  2011-07-15       Impact factor: 11.598

10.  Structures of KcsA in complex with symmetrical quaternary ammonium compounds reveal a hydrophobic binding site.

Authors:  Michael J Lenaeus; Dylan Burdette; Tobias Wagner; Pamela J Focia; Adrian Gross
Journal:  Biochemistry       Date:  2014-08-08       Impact factor: 3.162

View more
  35 in total

1.  Large-conductance Ca2+- and voltage-gated K+ channels form and break interactions with membrane lipids during each gating cycle.

Authors:  Yutao Tian; Stefan H Heinemann; Toshinori Hoshi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-09       Impact factor: 11.205

2.  Coupling stabilizers open KV1-type potassium channels.

Authors:  Malin Silverå Ejneby; Björn Wallner; Fredrik Elinder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-13       Impact factor: 11.205

3.  Polynuclear Ruthenium Amines Inhibit K2P Channels via a "Finger in the Dam" Mechanism.

Authors:  Lianne Pope; Marco Lolicato; Daniel L Minor
Journal:  Cell Chem Biol       Date:  2020-02-13       Impact factor: 8.116

4.  Selectivity filter instability dominates the low intrinsic activity of the TWIK-1 K2P K+ channel.

Authors:  Ehsan Nematian-Ardestani; Firdaus Abd-Wahab; Franck C Chatelain; Han Sun; Marcus Schewe; Thomas Baukrowitz; Stephen J Tucker
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

5.  The Polysite Pharmacology of TREK K2P Channels.

Authors:  Lianne Pope; Daniel L Minor
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Structural Basis for pH-gating of the K+ channel TWIK1 at the selectivity filter.

Authors:  Toby S Turney; Vivian Li; Stephen G Brohawn
Journal:  Nat Commun       Date:  2022-06-09       Impact factor: 17.694

7.  TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Authors:  Jérôme Busserolles; Ismail Ben Soussia; Laetitia Pouchol; Nicolas Marie; Mathieu Meleine; Maïly Devilliers; Céline Judon; Julien Schopp; Loïc Clémenceau; Laura Poupon; Eric Chapuy; Serge Richard; Florence Noble; Florian Lesage; Sylvie Ducki; Alain Eschalier; Stéphane Lolignier
Journal:  Br J Pharmacol       Date:  2020-09-21       Impact factor: 8.739

8.  Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate.

Authors:  Peter Proks; Marcus Schewe; Linus J Conrad; Shanlin Rao; Kristin Rathje; Karin E J Rödström; Elisabeth P Carpenter; Thomas Baukrowitz; Stephen J Tucker
Journal:  J Gen Physiol       Date:  2021-05-25       Impact factor: 4.086

9.  Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092.

Authors:  Yvonne Walsh; Michael Leach; Emma L Veale; Alistair Mathie
Journal:  Biochem Biophys Rep       Date:  2021-05-19

10.  The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels.

Authors:  Kevin P Cunningham; Lucie H Clapp; Alistair Mathie; Emma L Veale
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.